Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

That profile was merged into Kenneth Zaret.

Kenneth Zaret

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8932-3145; OpenAlex author ID A5049450448, A5082306721; NIH RePORTER profile ID 6746193. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 7)
Trials
0
Grants
2
Labs led
1
Collaborators
45
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper, 1 grant · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers, 1 grant

Papers 11

  1. Improving a Plasma Biomarker Panel for Early Detection of Pancreatic Ductal Adenocarcinoma with Aminopeptidase N (ANPEP) and Polymeric Immunoglobulin Receptor … Last author DOI 10.1158/1078-0432.ccr-25-3297↗
  2. Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study. Co-author DOI 10.1158/1078-0432.ccr-25-4061↗
  3. Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies. Co-author DOI 10.1016/j.pan.2024.10.012↗
  4. Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma. Last author DOI 10.18632/oncotarget.28127↗
  5. Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures. Last author DOI 10.1158/1541-7786.mcr-21-0483↗
  6. THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. Last author DOI 10.1158/1940-6207.capr-20-0403↗
  7. THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma. Last author DOI 10.18632/oncotarget.28099↗
  8. Generation of Induced Pluripotent Stem Cell-Like Lines from Human Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/978-1-4939-8879-2_4↗
  9. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Wo… Co-author DOI 10.1097/mpa.0000000000000973↗
  10. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. Last author DOI 10.1126/scitranslmed.aah5583↗
  11. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Last author DOI 10.1016/j.celrep.2013.05.036↗

Grants 2

  1. Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer U01CA210138↗
  2. Early Detection of PDAC in New-onset Diabetes and Other Cohorts AWARD pancan:2017-kenneth-zaret-early-detection-of-pdac-in-new-onset-dia

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shounak Majumder · 3 shared papers, 1 shared grant, 2024–2026 · strength 1.67
  2. Gloria M. Petersen · 2 shared papers, 1 shared grant, 2017–2026 · strength 1.20
  3. Ann L. Oberg · 5 shared papers, 2017–2026 · strength 0.86
  4. Erica L. Carpenter · 4 shared papers, 2021–2026 · strength 0.66
  5. Jungsun Kim · 5 shared papers, 2013–2021 · strength 0.56
  6. Jacob Edward Till · 3 shared papers, 2021–2026 · strength 0.53
  7. Phyllis A. Gimotty · 3 shared papers, 2021–2026 · strength 0.53
  8. Brianna M. Krusen · 2 shared papers, 2026 · strength 0.51
  9. Michael Goggins · 3 shared papers, 2018–2026 · strength 0.47
  10. Sudhir Srivastava · 3 shared papers, 2018–2026 · strength 0.47
  11. Suyu Liu · 2 shared papers, 2024–2026 · strength 0.39
  12. Lynette M. Smith · 2 shared papers, 2024–2026 · strength 0.39
  13. Brian Matthew Wolpin · 2 shared papers, 2024–2026 · strength 0.39
  14. Shirsa Udgata · 3 shared papers, 2021–2022 · strength 0.38
  15. Peter James O'Dwyer · 2 shared papers, 2021–2022 · strength 0.25
  16. Bryson W. Katona · 2 shared papers, 2021–2022 · strength 0.25
  17. Mark H. O’Hara · 2 shared papers, 2021–2022 · strength 0.25
  18. Kim A. Reiss · 2 shared papers, 2021–2022 · strength 0.25
  19. Subrata Sen · 1 shared paper, 2026 · strength 0.23
  20. Seetharaman Balasenthil · 1 shared paper, 2026 · strength 0.23
  21. Masataka Hayashi · 1 shared paper, 2026 · strength 0.23
  22. Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.23
  23. Surinder K. Batra · 1 shared paper, 2026 · strength 0.23
  24. Ann McNeill Killary · 1 shared paper, 2026 · strength 0.23
  25. Maneesh Jain · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.